Shopping Cart 0
Cart Subtotal
USD 0

Neurology devices Market by Product (Neurostimulation Devices, Neurosurgery Device, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices, and Others) and End User (Hospitals, Ambulatory Surgery Centers, and Neurology Clinics): Global Opportunity Analysis and Industry Forecast, 2019-2026

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 5370

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8995

Details

The global neurological devices market was valued at USD 9,242.67 million in 2018, and is expected to reach USD 17,410.40 million by 2026, registering a CAGR of 8.1% from 2019 to 2026. Neurovascular devices such as cerebrospinal fluid management devices and interventional devices majorly find their application in the treatment of neurological disorders, including Alzheimer's, tumors, depression, and stroke. Moreover, there are various other devices or instruments used for the treatment of neurological diseases such as catheters, stents, ultrasonic aspirators, and stereotactic system.
 
The growth of the global neurology devices market is driven by significant rise in geriatric population across the globe, rise in demand for minimally invasive surgeries, and development of advanced neurological devices. In addition, increase in prevalence of neurological disorders across the globe propels the demand for neurology devices, thereby supplementing the growth of the global market. In addition, rise in geriatric population poses risk for increase in incidence of neurovascular disorders (such as stroke). However, enforcement of stringent government regulations toward the approval of these devices and lack of skilled neurosurgeons are the key factors anticipated to hamper the market growth. Conversely, the introduction of new products and technological advancements in neurological devices have aided in the efficient treatment of many neurovascular disorders, which is expected to provide lucrative opportunities for market expansion during the forecast period.
 
The global neurological devices market is segmented into product, end user, and region. By product, the market is categorized into neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. Depending on end user, it is classified into hospitals, neurology clinics, and ambulatory care centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
 
KEY BENEFITS FOR STAKEHOLDERS
 
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of four regions is provided to determine the prevailing opportunities.
Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
 
KEY MARKET SEGMENTS
By Product
Neurostimulation Devices
Neurosurgery Devices
Interventional Neurology Devices
Cerebrospinal Fluid Devices
Others
By End User
Hospitals
Neurology Clinics
Ambulatory Care Centers
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
 
LIST OF KEY PLAYERS PROFILED IN THE REPORT
 
Abbott Laboratories
B. Braun Melsungen AG
Boston Scientific Corporation
Integra LifeSciences Holdings Corporation
LivaNova PLC
Johnson & Johnson
Medtronic Plc
Magstim Co Ltd.
Penumbra, Inc.
Stryker Corporation
 
READ MORE

Table Of Content

Scope

Chapter 1: Introduction

 

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Research Methodology

 

1.3.1. Secondary Research

1.3.2. Primary Research

1.3.3. Analyst Tools And Models

 

Chapter 2: Executive Summary

 

2.1. Key Findings of The Study

2.2. Cxo Perspective

 

Chapter 3: Market Overview

 

3.1. Market Definition And Scope

3.2. Key Findings

 

3.2.1. Top Investment Pockets

 

3.3. Porter'S Five Forces Analysis

 

3.3.1. Moderate Bargaining Power of Buyers

3.3.2. Low Bargaining Power of Suppliers

3.3.3. Moderate Threat of Substitutes

3.3.4. Low Threat of New Entrants

3.3.5. Moderate Competitive Rivalry

 

3.4. Top Player Positioning

3.5. Market Dynamics

 

3.5.1. Drivers

 

3.5.1.1. Surge In Neurological Disorders

3.5.1.2. Rising Demand For Noninvasive Diagnostic Techniques For Neurological Disorders

 

3.5.2. Restraint

 

3.5.2.1. Implementation of Stringent Government Regulations Towards Approval of Neurology Devices

 

3.5.3. Opportunity

 

3.5.3.1. Various Growth Opportunities In Emerging Economies

 

Chapter 4: Neurology Devices Market, By Product

 

4.1. Overview

 

4.1.1. Market Size And Forecast

 

4.2. Neurostimulation Devices

 

4.2.1. Key Market Trends And Opportunities

4.2.2. Market Size And Forecast

4.2.3. Market Share Analysis, By Country

 

4.3. Neurosurgery Device

 

4.3.1. Key Market Trends And Growth Opportunities

4.3.2. Market Size And Forecast

4.3.3. Market Share Analysis, By Country

 

4.4. Interventional Neurology Devices

 

4.4.1. Key Market Trends And Opportunities

4.4.2. Market Size And Forecast

4.4.3. Market Share Analysis, By Country

 

4.5. Cerebrospinal Fluid Management Devices

 

4.5.1. Key Market Trends And Opportunities

4.5.2. Market Size And Forecast

4.5.3. Market Share Analysis, By Country

 

4.6. Others

 

4.6.1. Key Market Trends And Opportunities

4.6.2. Market Size And Forecast

4.6.3. Market Share Analysis, By Country

 

Chapter 5: Neurology Devices Market, By End User

 

5.1. Overview

 

5.1.1. Market Size And Forecast

 

5.2. Hospitals

 

5.2.1. Market Size And Forecast

5.2.2. Market Share Analysis, By Country

 

5.3. Ambulatory Surgery Centers

 

5.3.1. Market Size And Forecast

5.3.2. Market Share Analysis, By Country

 

5.4. Neurology Clinics

 

5.4.1. Market Size And Forecast

5.4.2. Market Share Analysis, By Country

 

Chapter 6: Neurology Devices Market, By Region

 

6.1. Overview

 

6.1.1. Market Size And Forecast

 

6.2. North America

 

6.2.1. Key Market Trends And Opportunities

6.2.2. Market Size And Forecast, By Country

6.2.3. Market Size And Forecast, By Product

6.2.4. Market Size And Forecast, By End User

 

6.2.4.1. U.S. Market Size And Forecast, By Product

6.2.4.2. U.S. Market Size And Forecast, By End User

6.2.4.3. Canada Market Size And Forecast, By Product

6.2.4.4. Canada Market Size And Forecast, By End User

6.2.4.5. Mexico Market Size And Forecast, By Product

6.2.4.6. Mexico Market Size And Forecast, By End User

 

6.3. Europe

 

6.3.1. Key Growth Factors And Opportunities

6.3.2. Market Size And Forecast, By Country

6.3.3. Market Size And Forecast, By Product

6.3.4. Market Size And Forecast, By Product

 

6.3.4.1. Germany Market Size And Forecast, By Product

6.3.4.2. Germany Market Size And Forecast, By End User

6.3.4.3. France Market Size And Forecast, By Product

6.3.4.4. France Market Size And Forecast, By End User

6.3.4.5. Uk Market Size And Forecast, By End User

6.3.4.6. Uk Market Size And Forecast, By End User

6.3.4.7. Italy Market Size And Forecast, By Product

6.3.4.8. Italy Market Size And Forecast, By End User

6.3.4.10. Rest of Europe Market Size And Forecast, By Product

6.3.4.11. Rest of Europe Market Size And Forecast, By End User

 

6.4. Asia-Pacific

 

6.4.1. Key Growth Factors And Opportunities.

6.4.2. Market Size And Forecast, By Country

6.4.3. Market Size And Forecast, By Product

6.4.4. Market Size And Forecast, By End User

 

6.4.4.1. Japan Market Size And Forecast, By End User

6.4.4.2. Japan Market Size And Forecast, By End User

6.4.4.3. China Market Size And Forecast, By Product

6.4.4.4. China Market Size And Forecast, By End User

6.4.4.5. India Market Size And Forecast, By Product

6.4.4.6. India Market Size And Forecast, By End User

6.4.4.7. Rest of Asia-Pacific Market Size And Forecast, By Product

6.4.4.8. Rest of Asia-Pacific Market Size And Forecast, By End User

 

6.5. Lamea

 

6.5.1. Key Growth Factors And Opportunities

6.5.2. Market Size And Forecast, By Country

6.5.3. Market Size And Forecast, By Product

6.5.4. Market Size And Forecast, By End User

 

6.5.4.1. Brazil Market Size And Forecast, By End User

6.5.4.2. Brazil Market Size And Forecast, By End User

6.5.4.3. Saudi Arabia Market Size And Forecast, By Product

6.5.4.4. Saudi Arabia Market Size And Forecast, By End User

6.5.5.1. South Africa Market Size And Forecast, By Product

6.5.5.2. South Africa Market Size And Forecast, By End User

6.5.5.3. Rest of Lamea Market Size And Forecast, By Product

6.5.5.4. Rest of Lamea Market Size And Forecast, By End User

 

Chapter 7: Company Profiles

 

7.1. Abbott Laboratories

 

7.1.1. Company Overview

7.1.2. Company Snapshot

7.1.3. Operating Business Segments

7.1.4. Product Portfolio

7.1.5. Business Performance

 

7.2. B. Braun Melsungen Ag

 

7.2.1. Company Overview

7.2.2. Company Snapshot

7.2.3. Operating Business Segments

7.2.4. Product Portfolio

7.2.5. Business Performance

 

7.3. Boston Scientific Corporation

 

7.3.1. Company Overview

7.3.2. Company Snapshot

7.3.3. Operating Business Segments

7.3.4. Product Portfolio

7.3.5. Business Performance

7.3.6. Key Strategic Moves And Developments

 

7.4. Integra Lifesciences Holdings Corporation

 

7.4.1. Company Overview

7.4.2. Company Snapshot

7.4.3. Operating Business Segments

7.4.4. Product Portfolio

7.4.5. Business Performance

7.4.6. Key Strategic Moves And Developments

 

7.5. Johnson & Johnson

 

7.5.1. Company Overview

7.5.2. Company Snapshot

7.5.3. Operating Business Segments

7.5.4. Product Portfolio

7.5.5. Business Performance

 

7.6. Livanova Plc

 

7.6.1. Company Overview

7.6.2. Company Snapshot

7.6.3. Operating Business Segments

7.6.4. Product Portfolio

7.6.5. Business Performance

7.6.6. Key Strategic Moves And Developments

 

7.7. Medtronic Plc

 

7.7.1. Company Overview

7.7.2. Company Snapshot

7.7.3. Operating Business Segments

7.7.4. Product Portfolio

7.7.5. Business Performance

7.7.6. Key Strategic Moves And Developments

 

7.8. Magstim Co Ltd.

 

7.8.1. Company Overview

7.8.2. Operating Business Segments

7.8.3. Product Portfolio

7.8.4. Key Strategic Moves And Developments

 

7.9. Penumbra, Inc.

 

7.9.1. Company Overview

7.9.2. Company Snapshot

7.9.3. Operating Business Segments

7.9.4. Product Portfolio

7.9.5. Business Performance

 

7.10. Stryker Corporation

 

7.10.1. Company Overview

7.10.2. Company Snapshot

7.10.3. Operating Business Segments

7.10.4. Product Portfolio

7.10.5. Business Performance


List Of Figure

List of Figures

 

Figure 01. Global Neurology Devices Market Segmentation

Figure 02. Top Investment Pockets

Figure 03. Top Player Positioning

Figure 04. Global Neurology Devices Market: Drivers, Restraint, And Opportunity

Figure 05. Comparative Share Analysis of Neurostimulation Devices Market, By Country, 2018 & 2026 (%)

Figure 06. Comparative Share Analysis of Neurosurgery Devices Market, By Country, 2018 & 2026 (%)

Figure 07. Comparative Share Analysis of Interventional Neurology Devices Market, By Country, 2018 & 2026 (%)

Figure 08. Comparative Share Analysis of Cerebrospinal Fluid Management Devices Market, By Country, 2018 & 2026 (%)

Figure 09. Comparative Share Analysis of Other Devices, By Country, 2018 & 2026 (%)

Figure 10. Comparative Share Analysis of Neurology Devices Market For Hospitals, By Country, 2018 & 2026 (%)

Figure 11. Comparative Share Analysis of Neurology Devices Market For Ambulatory Surgery Centers, By Country, 2018 & 2026 (%)

Figure 12. Comparative Share Analysis of Neurology Devices Market For Neurology Clinics, By Country, 2018 & 2026 (%)

Figure 13. Abbott: Net Sales, 2016-2018 (USD Million)

Figure 14. Abbott: Revenue Share By Segment, 2018 (%)

Figure 15. Abbott: Revenue Share By Region, 2018 (%)

Figure 16. Net Sales, 2016-2018 (USD Million)

Figure 17. B. Braun: Net Sales By Division, 2018 (%)

Figure 18. B. Braun: Net Sales By Region, 2018 (%)

Figure 19. Boston Scientific: Net Sales, 2016-2018 (USD Million)

Figure 20. Boston Scientific: Revenue Share By Segment, 2018 (%)

Figure 21. Boston Scientific: Revenue Share By Geography, 2018 (%)

Figure 22. Integra: Revenue, 2016-2018 (USD Million)

Figure 23. Integra: Revenue Share By Segment, 2018 (%)

Figure 24. Integra: Revenue Share By Region, 2018 (%)

Figure 25. J&J: Net Sales, 2016-2018 (USD Million)

Figure 26. J&J: Revenue Share By Segmentation, 2016-2018(%)

Figure 27. J&J: Revenue Share By Region, 2016-2018(%)

Figure 28. Livanova: Revenue, 2016-2018 (USD Million)

Figure 29. Livanova: Revenue Share By Segment, 2018 (%)

Figure 30. Livanova: Revenue Share By Region, 2018 (%)

Figure 31. Medtronic: Net Sales, 2016-2018 (USD Million)

Figure 32. Medtronic: Revenue Share By Segment, 2018 (%)

Figure 33. Medtronic: Revenue Share By Region, 2018 (%)

Figure 34. Penumbra: Net Sales, 2016-2018(USD Million)

Figure 01. Penumbra: Revenue Share By Segment, 2018 (%)

Figure 02. Penumbra: Revenue Share By Region, 2018 (%)

Figure 03. Net Sales, 2016-2018 (USD Million)

Figure 04. Stryker: Revenue Share By Segment, 2018 (%)

Figure 05. Stryker: Revenue Share By Region, 2018 (%)


List Of Table

List of Tables

 

Table 01. Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 02. Neurostimulation Devices Market, By Region, 2018-2026 (USD Million)

Table 03. Neurosurgery Devices Market, By Region, 2018-2026 (USD Million)

Table 04. Interventional Neurology Devices Market, By Region, 2018-2026 (USD Million)

Table 05. Cerebrospinal Fluid Management Devices Market, By Region, 2018-2026 (USD Million)

Table 06. Other Devices Market, By Region, 2018-2026 (USD Million)

Table 07. Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 08. Neurology Devices Market For Hospitals, By Region, 2018-2026 (USD Million)

Table 09. Neurology Devices Market For Ambulatory Surgery Centers, By Region, 2018-2026 (USD Million)

Table 10. Neurology Devices Market For Neurology Clinics, By Region, 2018-2026 (USD Million)

Table 11. Global Neurology Devices Market, By Region, 2018-2026 (USD Million)

Table 12. North America Neurology Devices Market, By Country, 2018-2026 (USD Million)

Table 13. North America Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 14. North America Neurology Devices Market, By End User, 2018-2026 (USD Million),

Table 15. U.S. Neurology Devices Market By Product, 2018-2026 (USD Million)

Table 16. U.S. Neurology Devices Market By End User, 2018-2026 (USD Million)

Table 17. Canada Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 18. Canada Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 19. Mexico Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 20. Mexico Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 21. Europe Neurology Devices Market, By Country, 2018-2026 (USD Million)

Table 22. Europe Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 23. Europe Neurology Devices Market, By End User, 2018-2026 (USD Million),

Table 24. Germany Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 25. Germany Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 26. France Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 27. France Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 28. U.K. Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 29. U.K. Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 30. Italy Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 31. Italy Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 32. Rest of Europe Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 33. Rest of Europe Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 34. Asia-Pacific Neurology Devices Market, By Country, 2018-2026 (USD Million)

Table 35. Asia-Pacific Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 36. Asia-Pacific Neurology Devices Market, By End User, 2018-2026 (USD Million),

Table 37. Japan Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 38. Japan Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 39. China Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 40. China Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 41. India Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 42. India Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 43. Rest of Asia-Pacific Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 44. Rest of Asia-Pacific Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 45. Lamea Neurology Devices Market, By Country, 2018-2026 (USD Million)

Table 46. Lamea Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 47. Lamea Neurology Devices Market, By End User, 2018-2026 (USD Million),

Table 48. Brazil Neurology Devices Market, By Product 2018-2026 (USD Million)

Table 49. Brazil Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 50. Saudi Arabia Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 51. Saudi Arabia Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 52. South Africa Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 53. South Africa Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 54. Rest of Lamea Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 55. Rest of Lamea Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 56. Abbott: Company Snapshot

Table 57. Abbott: Operating Segments

Table 58. Abbott: Product Portfolio

Table 59. B. Braun: Company Snapshot

Table 60. B. Braun: Operating Segments

Table 61. B. Braun: Product Portfolio

Table 62. Boston Scientific: Company Snapshot

Table 63. Boston Scientific: Operating Segments

Table 64. Boston Scientific: Product Portfolio

Table 65. Integra: Company Snapshot

Table 66. Integra: Operating Segments

Table 67. Integra: Product Portfolio

Table 68. Johnson & Johnson: Company Snapshot

Table 69. J&J: Operating Segment

Table 70. J&J.: Product Portfolio

Table 71. Livanova: Company Snapshot

Table 72. Livanova: Operating Segment

Table 73. Livanova: Product Portfolio

Table 74. Medtronic: Company Snapshot

Table 75. Medtronic: Operating Segments

Table 76. Medtronic: Product Portfolio

Table 77. Magstim: Operating Segment

Table 78. Magstim: Product Portfolio

Table 79. Penumbra.: Company Snapshot

Table 80. Penumbra.: Operating Segments

Table 81. Penumbra.: Product Portfolio

Table 82. Stryker: Company Snapshot

Table 83. Stryker: Operating Segments

Table 84. Stryker: Product Portfolio

Licence Rights

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Abbott Laboratories., B. Braun Melsungen AG, Boston Scientific Corporation., Integra LifeSciences Holdings Corporation, LivaNova PLC, Johnson & Johnson, Medtronic Plc., Magstim Co Ltd., Penumbra, Inc., and Stryker Corporation

Company Profile

Company Profile Title

The global neurological devices market was valued at USD 9,242.67 million in 2018, and is expected to reach USD 17,410.40 million by 2026, registering a CAGR of 8.1% from 2019 to 2026. Neurovascular devices such as cerebrospinal fluid management devices and interventional devices majorly find their application in the treatment of neurological disorders, including Alzheimer's, tumors, depression, and stroke. Moreover, there are various other devices or instruments used for the treatment of neurological diseases such as catheters, stents, ultrasonic aspirators, and stereotactic system.
 
The growth of the global neurology devices market is driven by significant rise in geriatric population across the globe, rise in demand for minimally invasive surgeries, and development of advanced neurological devices. In addition, increase in prevalence of neurological disorders across the globe propels the demand for neurology devices, thereby supplementing the growth of the global market. In addition, rise in geriatric population poses risk for increase in incidence of neurovascular disorders (such as stroke). However, enforcement of stringent government regulations toward the approval of these devices and lack of skilled neurosurgeons are the key factors anticipated to hamper the market growth. Conversely, the introduction of new products and technological advancements in neurological devices have aided in the efficient treatment of many neurovascular disorders, which is expected to provide lucrative opportunities for market expansion during the forecast period.
 
The global neurological devices market is segmented into product, end user, and region. By product, the market is categorized into neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. Depending on end user, it is classified into hospitals, neurology clinics, and ambulatory care centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
 
KEY BENEFITS FOR STAKEHOLDERS
 
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of four regions is provided to determine the prevailing opportunities.
Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
 
KEY MARKET SEGMENTS
By Product
Neurostimulation Devices
Neurosurgery Devices
Interventional Neurology Devices
Cerebrospinal Fluid Devices
Others
By End User
Hospitals
Neurology Clinics
Ambulatory Care Centers
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
 
LIST OF KEY PLAYERS PROFILED IN THE REPORT
 
Abbott Laboratories
B. Braun Melsungen AG
Boston Scientific Corporation
Integra LifeSciences Holdings Corporation
LivaNova PLC
Johnson & Johnson
Medtronic Plc
Magstim Co Ltd.
Penumbra, Inc.
Stryker Corporation
 
READ MORE

Scope

Chapter 1: Introduction

 

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Research Methodology

 

1.3.1. Secondary Research

1.3.2. Primary Research

1.3.3. Analyst Tools And Models

 

Chapter 2: Executive Summary

 

2.1. Key Findings of The Study

2.2. Cxo Perspective

 

Chapter 3: Market Overview

 

3.1. Market Definition And Scope

3.2. Key Findings

 

3.2.1. Top Investment Pockets

 

3.3. Porter'S Five Forces Analysis

 

3.3.1. Moderate Bargaining Power of Buyers

3.3.2. Low Bargaining Power of Suppliers

3.3.3. Moderate Threat of Substitutes

3.3.4. Low Threat of New Entrants

3.3.5. Moderate Competitive Rivalry

 

3.4. Top Player Positioning

3.5. Market Dynamics

 

3.5.1. Drivers

 

3.5.1.1. Surge In Neurological Disorders

3.5.1.2. Rising Demand For Noninvasive Diagnostic Techniques For Neurological Disorders

 

3.5.2. Restraint

 

3.5.2.1. Implementation of Stringent Government Regulations Towards Approval of Neurology Devices

 

3.5.3. Opportunity

 

3.5.3.1. Various Growth Opportunities In Emerging Economies

 

Chapter 4: Neurology Devices Market, By Product

 

4.1. Overview

 

4.1.1. Market Size And Forecast

 

4.2. Neurostimulation Devices

 

4.2.1. Key Market Trends And Opportunities

4.2.2. Market Size And Forecast

4.2.3. Market Share Analysis, By Country

 

4.3. Neurosurgery Device

 

4.3.1. Key Market Trends And Growth Opportunities

4.3.2. Market Size And Forecast

4.3.3. Market Share Analysis, By Country

 

4.4. Interventional Neurology Devices

 

4.4.1. Key Market Trends And Opportunities

4.4.2. Market Size And Forecast

4.4.3. Market Share Analysis, By Country

 

4.5. Cerebrospinal Fluid Management Devices

 

4.5.1. Key Market Trends And Opportunities

4.5.2. Market Size And Forecast

4.5.3. Market Share Analysis, By Country

 

4.6. Others

 

4.6.1. Key Market Trends And Opportunities

4.6.2. Market Size And Forecast

4.6.3. Market Share Analysis, By Country

 

Chapter 5: Neurology Devices Market, By End User

 

5.1. Overview

 

5.1.1. Market Size And Forecast

 

5.2. Hospitals

 

5.2.1. Market Size And Forecast

5.2.2. Market Share Analysis, By Country

 

5.3. Ambulatory Surgery Centers

 

5.3.1. Market Size And Forecast

5.3.2. Market Share Analysis, By Country

 

5.4. Neurology Clinics

 

5.4.1. Market Size And Forecast

5.4.2. Market Share Analysis, By Country

 

Chapter 6: Neurology Devices Market, By Region

 

6.1. Overview

 

6.1.1. Market Size And Forecast

 

6.2. North America

 

6.2.1. Key Market Trends And Opportunities

6.2.2. Market Size And Forecast, By Country

6.2.3. Market Size And Forecast, By Product

6.2.4. Market Size And Forecast, By End User

 

6.2.4.1. U.S. Market Size And Forecast, By Product

6.2.4.2. U.S. Market Size And Forecast, By End User

6.2.4.3. Canada Market Size And Forecast, By Product

6.2.4.4. Canada Market Size And Forecast, By End User

6.2.4.5. Mexico Market Size And Forecast, By Product

6.2.4.6. Mexico Market Size And Forecast, By End User

 

6.3. Europe

 

6.3.1. Key Growth Factors And Opportunities

6.3.2. Market Size And Forecast, By Country

6.3.3. Market Size And Forecast, By Product

6.3.4. Market Size And Forecast, By Product

 

6.3.4.1. Germany Market Size And Forecast, By Product

6.3.4.2. Germany Market Size And Forecast, By End User

6.3.4.3. France Market Size And Forecast, By Product

6.3.4.4. France Market Size And Forecast, By End User

6.3.4.5. Uk Market Size And Forecast, By End User

6.3.4.6. Uk Market Size And Forecast, By End User

6.3.4.7. Italy Market Size And Forecast, By Product

6.3.4.8. Italy Market Size And Forecast, By End User

6.3.4.10. Rest of Europe Market Size And Forecast, By Product

6.3.4.11. Rest of Europe Market Size And Forecast, By End User

 

6.4. Asia-Pacific

 

6.4.1. Key Growth Factors And Opportunities.

6.4.2. Market Size And Forecast, By Country

6.4.3. Market Size And Forecast, By Product

6.4.4. Market Size And Forecast, By End User

 

6.4.4.1. Japan Market Size And Forecast, By End User

6.4.4.2. Japan Market Size And Forecast, By End User

6.4.4.3. China Market Size And Forecast, By Product

6.4.4.4. China Market Size And Forecast, By End User

6.4.4.5. India Market Size And Forecast, By Product

6.4.4.6. India Market Size And Forecast, By End User

6.4.4.7. Rest of Asia-Pacific Market Size And Forecast, By Product

6.4.4.8. Rest of Asia-Pacific Market Size And Forecast, By End User

 

6.5. Lamea

 

6.5.1. Key Growth Factors And Opportunities

6.5.2. Market Size And Forecast, By Country

6.5.3. Market Size And Forecast, By Product

6.5.4. Market Size And Forecast, By End User

 

6.5.4.1. Brazil Market Size And Forecast, By End User

6.5.4.2. Brazil Market Size And Forecast, By End User

6.5.4.3. Saudi Arabia Market Size And Forecast, By Product

6.5.4.4. Saudi Arabia Market Size And Forecast, By End User

6.5.5.1. South Africa Market Size And Forecast, By Product

6.5.5.2. South Africa Market Size And Forecast, By End User

6.5.5.3. Rest of Lamea Market Size And Forecast, By Product

6.5.5.4. Rest of Lamea Market Size And Forecast, By End User

 

Chapter 7: Company Profiles

 

7.1. Abbott Laboratories

 

7.1.1. Company Overview

7.1.2. Company Snapshot

7.1.3. Operating Business Segments

7.1.4. Product Portfolio

7.1.5. Business Performance

 

7.2. B. Braun Melsungen Ag

 

7.2.1. Company Overview

7.2.2. Company Snapshot

7.2.3. Operating Business Segments

7.2.4. Product Portfolio

7.2.5. Business Performance

 

7.3. Boston Scientific Corporation

 

7.3.1. Company Overview

7.3.2. Company Snapshot

7.3.3. Operating Business Segments

7.3.4. Product Portfolio

7.3.5. Business Performance

7.3.6. Key Strategic Moves And Developments

 

7.4. Integra Lifesciences Holdings Corporation

 

7.4.1. Company Overview

7.4.2. Company Snapshot

7.4.3. Operating Business Segments

7.4.4. Product Portfolio

7.4.5. Business Performance

7.4.6. Key Strategic Moves And Developments

 

7.5. Johnson & Johnson

 

7.5.1. Company Overview

7.5.2. Company Snapshot

7.5.3. Operating Business Segments

7.5.4. Product Portfolio

7.5.5. Business Performance

 

7.6. Livanova Plc

 

7.6.1. Company Overview

7.6.2. Company Snapshot

7.6.3. Operating Business Segments

7.6.4. Product Portfolio

7.6.5. Business Performance

7.6.6. Key Strategic Moves And Developments

 

7.7. Medtronic Plc

 

7.7.1. Company Overview

7.7.2. Company Snapshot

7.7.3. Operating Business Segments

7.7.4. Product Portfolio

7.7.5. Business Performance

7.7.6. Key Strategic Moves And Developments

 

7.8. Magstim Co Ltd.

 

7.8.1. Company Overview

7.8.2. Operating Business Segments

7.8.3. Product Portfolio

7.8.4. Key Strategic Moves And Developments

 

7.9. Penumbra, Inc.

 

7.9.1. Company Overview

7.9.2. Company Snapshot

7.9.3. Operating Business Segments

7.9.4. Product Portfolio

7.9.5. Business Performance

 

7.10. Stryker Corporation

 

7.10.1. Company Overview

7.10.2. Company Snapshot

7.10.3. Operating Business Segments

7.10.4. Product Portfolio

7.10.5. Business Performance


List Of Figure

List of Figures

 

Figure 01. Global Neurology Devices Market Segmentation

Figure 02. Top Investment Pockets

Figure 03. Top Player Positioning

Figure 04. Global Neurology Devices Market: Drivers, Restraint, And Opportunity

Figure 05. Comparative Share Analysis of Neurostimulation Devices Market, By Country, 2018 & 2026 (%)

Figure 06. Comparative Share Analysis of Neurosurgery Devices Market, By Country, 2018 & 2026 (%)

Figure 07. Comparative Share Analysis of Interventional Neurology Devices Market, By Country, 2018 & 2026 (%)

Figure 08. Comparative Share Analysis of Cerebrospinal Fluid Management Devices Market, By Country, 2018 & 2026 (%)

Figure 09. Comparative Share Analysis of Other Devices, By Country, 2018 & 2026 (%)

Figure 10. Comparative Share Analysis of Neurology Devices Market For Hospitals, By Country, 2018 & 2026 (%)

Figure 11. Comparative Share Analysis of Neurology Devices Market For Ambulatory Surgery Centers, By Country, 2018 & 2026 (%)

Figure 12. Comparative Share Analysis of Neurology Devices Market For Neurology Clinics, By Country, 2018 & 2026 (%)

Figure 13. Abbott: Net Sales, 2016-2018 (USD Million)

Figure 14. Abbott: Revenue Share By Segment, 2018 (%)

Figure 15. Abbott: Revenue Share By Region, 2018 (%)

Figure 16. Net Sales, 2016-2018 (USD Million)

Figure 17. B. Braun: Net Sales By Division, 2018 (%)

Figure 18. B. Braun: Net Sales By Region, 2018 (%)

Figure 19. Boston Scientific: Net Sales, 2016-2018 (USD Million)

Figure 20. Boston Scientific: Revenue Share By Segment, 2018 (%)

Figure 21. Boston Scientific: Revenue Share By Geography, 2018 (%)

Figure 22. Integra: Revenue, 2016-2018 (USD Million)

Figure 23. Integra: Revenue Share By Segment, 2018 (%)

Figure 24. Integra: Revenue Share By Region, 2018 (%)

Figure 25. J&J: Net Sales, 2016-2018 (USD Million)

Figure 26. J&J: Revenue Share By Segmentation, 2016-2018(%)

Figure 27. J&J: Revenue Share By Region, 2016-2018(%)

Figure 28. Livanova: Revenue, 2016-2018 (USD Million)

Figure 29. Livanova: Revenue Share By Segment, 2018 (%)

Figure 30. Livanova: Revenue Share By Region, 2018 (%)

Figure 31. Medtronic: Net Sales, 2016-2018 (USD Million)

Figure 32. Medtronic: Revenue Share By Segment, 2018 (%)

Figure 33. Medtronic: Revenue Share By Region, 2018 (%)

Figure 34. Penumbra: Net Sales, 2016-2018(USD Million)

Figure 01. Penumbra: Revenue Share By Segment, 2018 (%)

Figure 02. Penumbra: Revenue Share By Region, 2018 (%)

Figure 03. Net Sales, 2016-2018 (USD Million)

Figure 04. Stryker: Revenue Share By Segment, 2018 (%)

Figure 05. Stryker: Revenue Share By Region, 2018 (%)


List Of Table

List of Tables

 

Table 01. Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 02. Neurostimulation Devices Market, By Region, 2018-2026 (USD Million)

Table 03. Neurosurgery Devices Market, By Region, 2018-2026 (USD Million)

Table 04. Interventional Neurology Devices Market, By Region, 2018-2026 (USD Million)

Table 05. Cerebrospinal Fluid Management Devices Market, By Region, 2018-2026 (USD Million)

Table 06. Other Devices Market, By Region, 2018-2026 (USD Million)

Table 07. Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 08. Neurology Devices Market For Hospitals, By Region, 2018-2026 (USD Million)

Table 09. Neurology Devices Market For Ambulatory Surgery Centers, By Region, 2018-2026 (USD Million)

Table 10. Neurology Devices Market For Neurology Clinics, By Region, 2018-2026 (USD Million)

Table 11. Global Neurology Devices Market, By Region, 2018-2026 (USD Million)

Table 12. North America Neurology Devices Market, By Country, 2018-2026 (USD Million)

Table 13. North America Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 14. North America Neurology Devices Market, By End User, 2018-2026 (USD Million),

Table 15. U.S. Neurology Devices Market By Product, 2018-2026 (USD Million)

Table 16. U.S. Neurology Devices Market By End User, 2018-2026 (USD Million)

Table 17. Canada Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 18. Canada Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 19. Mexico Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 20. Mexico Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 21. Europe Neurology Devices Market, By Country, 2018-2026 (USD Million)

Table 22. Europe Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 23. Europe Neurology Devices Market, By End User, 2018-2026 (USD Million),

Table 24. Germany Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 25. Germany Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 26. France Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 27. France Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 28. U.K. Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 29. U.K. Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 30. Italy Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 31. Italy Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 32. Rest of Europe Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 33. Rest of Europe Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 34. Asia-Pacific Neurology Devices Market, By Country, 2018-2026 (USD Million)

Table 35. Asia-Pacific Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 36. Asia-Pacific Neurology Devices Market, By End User, 2018-2026 (USD Million),

Table 37. Japan Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 38. Japan Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 39. China Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 40. China Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 41. India Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 42. India Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 43. Rest of Asia-Pacific Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 44. Rest of Asia-Pacific Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 45. Lamea Neurology Devices Market, By Country, 2018-2026 (USD Million)

Table 46. Lamea Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 47. Lamea Neurology Devices Market, By End User, 2018-2026 (USD Million),

Table 48. Brazil Neurology Devices Market, By Product 2018-2026 (USD Million)

Table 49. Brazil Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 50. Saudi Arabia Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 51. Saudi Arabia Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 52. South Africa Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 53. South Africa Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 54. Rest of Lamea Neurology Devices Market, By Product, 2018-2026 (USD Million)

Table 55. Rest of Lamea Neurology Devices Market, By End User, 2018-2026 (USD Million)

Table 56. Abbott: Company Snapshot

Table 57. Abbott: Operating Segments

Table 58. Abbott: Product Portfolio

Table 59. B. Braun: Company Snapshot

Table 60. B. Braun: Operating Segments

Table 61. B. Braun: Product Portfolio

Table 62. Boston Scientific: Company Snapshot

Table 63. Boston Scientific: Operating Segments

Table 64. Boston Scientific: Product Portfolio

Table 65. Integra: Company Snapshot

Table 66. Integra: Operating Segments

Table 67. Integra: Product Portfolio

Table 68. Johnson & Johnson: Company Snapshot

Table 69. J&J: Operating Segment

Table 70. J&J.: Product Portfolio

Table 71. Livanova: Company Snapshot

Table 72. Livanova: Operating Segment

Table 73. Livanova: Product Portfolio

Table 74. Medtronic: Company Snapshot

Table 75. Medtronic: Operating Segments

Table 76. Medtronic: Product Portfolio

Table 77. Magstim: Operating Segment

Table 78. Magstim: Product Portfolio

Table 79. Penumbra.: Company Snapshot

Table 80. Penumbra.: Operating Segments

Table 81. Penumbra.: Product Portfolio

Table 82. Stryker: Company Snapshot

Table 83. Stryker: Operating Segments

Table 84. Stryker: Product Portfolio

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Abbott Laboratories., B. Braun Melsungen AG, Boston Scientific Corporation., Integra LifeSciences Holdings Corporation, LivaNova PLC, Johnson & Johnson, Medtronic Plc., Magstim Co Ltd., Penumbra, Inc., and Stryker Corporation